Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Lecanemab Nabs Accelerated Approval in US, Set to Hit Market Late January
January 10, 2023
- Takeda’s TAK-755 Shows Promising PIII Interim Data for Ultra-Rare Blood Clotting Disorder
January 10, 2023
- Kaken Earns Japan Rights to CAH Med, Poised to Boost Rare Disease Biz
January 10, 2023
- Nippon Shinyaku Launches Open Innovation-Driven Drug Discovery Hub in US
January 10, 2023
- Fujifilm US Subsidiary Licenses iPSC Platform to Novo
January 10, 2023
- US Federal Circuit Nixes Lexiscan Patent Infringement, Astellas to File Appeal
January 6, 2023
- Dayvigo Tops HP Ranking, Twymeeg Most Promoted in GP Market 5 Months Running in November: Intage
January 6, 2023
- Shionogi Reports 2 Serious Side Effect Cases in Xocova Update
January 6, 2023
- Xocova Filed for Conditional Approval in South Korea
January 6, 2023
- Enhertu’s Application for NSCLC Use Accepted in Europe: Daiichi Sankyo
January 6, 2023
- Moderna Snags Tokyo Upstart in Its 1st M&A Deal, Staff to Join Japan Unit
January 6, 2023
- Creditors Approve Nichi-Iko’s Turnaround Scheme, Grants Debt Waiver of 98.5 Billion Yen
January 5, 2023
- Steve Sugino Becomes New CEO of BMS Japan
January 5, 2023
- Japan Likely to See Generic Listing for Azilva, Zytiga in 2023; Xarelto AG Rivals Too
January 5, 2023
- Sun Pharma Japan Gearing Up Sales of Flagship Dermatology Med Ilumya: President
December 28, 2022
- RaQualia, Veritas Seal mRNA Drug Discovery Collaboration
December 28, 2022
- PeptiDream, Lilly Ink Collab with Up to US$1.2 Billion in Milestones
December 27, 2022
- Estimated 4,640 Patients Took Xocova by Dec. 18: Shionogi
December 27, 2022
- SymBio, Eagle Take Pfizer Japan to Court after Treakisym Gx Launch
December 27, 2022
- Towa Hopes to Resume Meropenem 0.5 g Shipment in March
December 27, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…